Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: 52-Week Data From the Phase 4 ARTISTYK Study. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Apr. 21];9(6):s649. Available from: https://skin.dermsquared.com/skin/article/view/3903